Fengqiao Li
- Molecular Biology top 10%
- Biomedical Engineering top 10%
- Cancer Research top 10%
- Biomaterials top 5%
- Complementary and alternative medicine top 1%
- Topics
- RNA Interference and Gene Delivery (8 papers)Neuroinflammation and Neurodegeneration Mechanisms (6 papers)Natural Compounds in Disease Treatment (6 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Fengqiao Li
35 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.2k
- Biomedical Engineering 343
- Cancer Research 282
- Biomaterials 281
- Complementary and alternative medicine 275
Countries citing papers authored by Fengqiao Li
This map shows the geographic impact of Fengqiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengqiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengqiao Li more than expected).
Fields of papers citing papers by Fengqiao Li
This network shows the impact of papers produced by Fengqiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengqiao Li. The network helps show where Fengqiao Li may publish in the future.
Co-authorship network of co-authors of Fengqiao Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fengqiao Li. A scholar is included among the top collaborators of Fengqiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengqiao Li. Fengqiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapybreakdown → | 52 |
| 3 | mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapybreakdown → | 98 |
| 4 | 0 | |
| 5 | 38 | |
| 6 | 87 | |
| 7 | 71 | |
| 8 | 27 | |
| 9 | 130 | |
| 10 | 28 | |
| 11 | 25 | |
| 12 | 146 | |
| 13 | 61 | |
| 14 | 28 | |
| 15 | 78 | |
| 16 | 91 | |
| 17 | 58 | |
| 18 | 61 | |
| 19 | 65 | |
| 20 | 53 |
About Fengqiao Li
Fengqiao Li is a scholar working on Complementary and alternative medicine, Neurology and Developmental Neuroscience, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Natural Compounds in Disease Treatment (6 papers). The work is most often cited by research in Complementary and alternative medicine (275 citations), Neurology (199 citations) and Biomaterials (281 citations). Fengqiao Li has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xiaoyang Xu, Xue‐Qing Zhang, Lee Jia, Xiaodong Xie, William Ho, Zhongyu Li, Yu Gao, Michael P. Vitek, Huifang Nie and Mingzhu Gao. Their work appears in journals such as Nature Communications, ACS Nano and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.